Skip to main content
. 2024 Sep 18;11(9):ofae512. doi: 10.1093/ofid/ofae512

Table 3.

STI Infection Among all Patients Undergoing mpox Testing by Site

Diagnosis Site
Total ID PCP ED P value
Any positive STI (n = 154)a .080
 Yes 19 (12.3%) 8 (19.5%) 0 (0.0%) 11 (11.8%)
 No 135 (87.7%) 33 (80.5%) 20 (100.0%) 82 (88.2%)
Positive HIV (n = 77)b -
 Yes 0 (0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
 No 77 (100%) 4 (100.0%) 15 (100.0%) 58 (100.0%)
Positive gonorrhea (n = 105) .413
 Yes 5 (4.8%) 3 (8.1%) 0 (0.0%) 2 (3.6%)
 No 100 (95.2%) 34 (91.9%) 12 (100.0%) 54 (96.4%)
Positive chlamydia (n = 105) .780
 Yes 4 (3.8%) 2 (5.6%) 0 (0.0%) 2 (3.5%)
 No 101 (96.2%) 34 (94.4%) 12 (100.0%) 55 (96.5%)
Positive extragenital gonorrhea (n = 52) .695
 Yes 3 (5.8%) 3 (8.8%) 0 (0.0%) 0 (0%)
 No 49 (94.2%) 31 (91.2%) 6 (100%) 12 (100%)
Positive extragenital chlamydia (n = 52) 1.000
 Yes 2 (3.8%) 2 (6.1%) 0 (0.0%) 0 (0.0%)
 No 50 (96.2%) 31 (93.9%) 6 (100.0%) 13 (100.0%)
New syphilis diagnosis (n = 110) .504
 Yes 14 (12.7%) 4 (15.4%) 0 (0.0%) 10 (13.9%)
 No 96 (87.3%) 22 (84.6%) 12 (100.0%) 62 (86.1%)

Abbreviations: ED, emergency department; ID, infectious diseases; PCP, primary care provider; STI, sexually transmitted infection.

aAny positive STI (gonorrhea, chlamydia, syphilis or HIV) excluding mpox.

bExcluding patients with known HIV positive status.